SCLC
Clinical trials for SCLC explained in plain language.
Never miss a new study
Get alerted when new SCLC trials appear
Sign up with your email to follow new studies for SCLC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail targets tough cancers in early trial
Disease control CompletedThis study tests a combination of two drugs, sacituzumab govitecan and berzosertib, in adults with small cell lung cancer or cancers that have stopped responding to PARP inhibitors. The goal is to find a safe dose and see if the combo can shrink tumors. Participants receive the d…
Matched conditions: SCLC
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New cocktail shows promise for tough lung cancer
Disease control CompletedThis study tested a combination of three drugs—nivolumab, ipilimumab, and plinabulin—in 39 adults with recurrent small cell lung cancer that had worsened after initial chemotherapy. The goal was to find the safest dose and see if the combo could slow cancer growth. Results from t…
Matched conditions: SCLC
Phase: PHASE1, PHASE2 • Sponsor: Salma Sabbour • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC